---
document_datetime: 2025-10-17 14:58:12
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/mynzepli-epar-all-authorised-presentations_en.pdf
document_name: mynzepli-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7868264
conversion_datetime: 2025-12-22 13:18:50.543608
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging        | Content (concentration)   | Pack size                |
|------------------|-------------------|------------|------------------------|---------------------------|----------------------------|---------------------------|--------------------------|
| EU/1/25/1964/001 | MYNZEPLI          | 40 mg/ml   | Solution for injection | Intravitreal use          | vial (glass)               | 0.1 ml                    | 1 vial + 1 filter needle |
| EU/1/25/1964/002 | MYNZEPLI          | 40 mg/ml   | Solution for injection | Intravitreal use          | pre-filled syringe (glass) | 0.09 ml                   | 1 pre-filled syringe     |